SONM DNA X, Inc.
Telephone & Telegraph Apparatus · Nasdaq · SEC CIK 1178697 · Fiscal year ends 12/31
Financial factors as of 2025-09-30 (2025Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY4.2%
TTM net income YoY-149.4%
TTM EPS YoY-115.8%
Revenue 3-yr CAGR-1.4%
Net income 3-yr CAGR—
Margins
Gross margin18.3%
Operating margin-48.1%
Net margin-56.5%
FCF margin—
EBITDA margin-41.8%
Returns
ROE-455.8%
ROA-74.7%
ROIC (approx.)-527.3%
Asset turnover1.32x
Leverage & solvency
Liabilities / assets101.7%
Debt / equity—
Current ratio0.78x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.78x
Accruals ratio-16.5%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | — | $58.30M | $93.63M | $69.83M | $54.57M |
| Cost of revenue | — | $48.38M | $74.31M | $58.20M | $48.16M |
| Gross profit | — | $9.92M | $19.32M | $11.62M | $6.41M |
| R&D expense | — | $14.23M | $1.77M | $7.97M | $17.70M |
| SG&A expense | $5.41M | $3.10M | $8.27M | $10.67M | $10.28M |
| Operating income | -$5.41M | -$3.10M | $513,000 | -$14.29M | -$38.00M |
| Interest expense | $945,000 | — | — | $97,000 | — |
| Pretax income | -$7.96M | -$2.88M | $284,000 | -$13.90M | -$38.46M |
| Income tax | -$1.15M | $226,000 | $374,000 | $184,000 | $167,000 |
| Net income | -$20.66M | -$33.65M | -$90,000 | -$14.09M | -$38.63M |
| EBITDA | -$1.11M | $457,000 | $2.72M | -$11.91M | -$35.87M |
| EPS (basic) | -28.58 | -128.37 | -0.02 | -0.49 | -4.08 |
| EPS (diluted) | -28.58 | -128.37 | -0.02 | -0.49 | -4.08 |
| Weighted avg. shares (diluted) | 722,689 | 262,118 | 4.29M | 28.89M | 9.46M |
| Banking | |||||
| Provision for credit losses | — | $2.29M | $159,000 | $5,000 | — |
| Balance sheet | |||||
| Cash & equivalents | $1.30M | $5.34M | $9.40M | $13.21M | $11.23M |
| Receivables | — | $4.34M | $25.30M | $22.43M | $10.80M |
| Inventory | — | $10.62M | $6.52M | $3.91M | $5.54M |
| Current assets | $28.91M | $32.16M | $43.79M | $43.63M | $35.69M |
| PP&E, net | — | $227,000 | $71,000 | $168,000 | $534,000 |
| Total assets | $43.90M | $39.74M | $56.04M | $53.69M | $41.09M |
| Current liabilities | $50.62M | $43.74M | $32.15M | $32.06M | $20.98M |
| Short-term debt | $5.07M | — | — | $147,000 | $148,000 |
| Long-term debt | $5.07M | — | — | — | $66,000 |
| Total debt | $10.13M | — | — | — | $214,000 |
| Total liabilities | $50.62M | $45.44M | $33.67M | $33.64M | $22.46M |
| Shareholders' equity | -$7.96M | -$5.70M | $22.37M | $20.05M | $18.63M |
| Net debt | $8.83M | — | — | — | -$11.02M |
| Shares outstanding | 1.27M | 276,881 | 4.43M | 40.77M | 18.81M |
| Cash flow statement | |||||
| Operating cash flow | -$23.53M | -$8.49M | -$4.05M | -$12.36M | -$38.48M |
| Capital expenditure | — | $214,000 | $36,000 | $8,000 | $46,000 |
| Free cash flow | — | -$8.70M | -$4.09M | -$12.37M | -$38.52M |
| Investing cash flow | — | -$214,000 | -$36,000 | -$8,000 | -$46,000 |
| Financing cash flow | $19.49M | $4.65M | $272,000 | $14.35M | $27.61M |
| Depreciation & amortization | $4.30M | $3.56M | $2.21M | $2.38M | $2.13M |
| Stock-based compensation | $1.54M | $1.52M | $1.50M | $1.55M | $1.08M |
Free plan shows the latest 5 periods; Pro shows all 8 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.